37,298 Shares in iShares Biotechnology ETF $IBB Bought by Equitable Trust Co.

Equitable Trust Co. bought a new position in iShares Biotechnology ETF (NASDAQ:IBB) in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 37,298 shares of the financial services provider’s stock, valued at approximately $6,298,000. Equitable Trust Co. owned approximately 0.08% of iShares Biotechnology ETF as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of IBB. Hsbc Holdings PLC boosted its stake in shares of iShares Biotechnology ETF by 14.5% during the first quarter. Hsbc Holdings PLC now owns 3,617 shares of the financial services provider’s stock valued at $610,000 after purchasing an additional 459 shares in the last quarter. First Horizon Corp raised its holdings in iShares Biotechnology ETF by 9.8% in the 1st quarter. First Horizon Corp now owns 2,042 shares of the financial services provider’s stock valued at $345,000 after buying an additional 182 shares during the last quarter. Kestra Advisory Services LLC raised its holdings in iShares Biotechnology ETF by 12.2% in the 1st quarter. Kestra Advisory Services LLC now owns 47,461 shares of the financial services provider’s stock valued at $8,014,000 after buying an additional 5,155 shares during the last quarter. First Interstate Bank raised its holdings in iShares Biotechnology ETF by 18.7% in the 1st quarter. First Interstate Bank now owns 41,082 shares of the financial services provider’s stock valued at $6,937,000 after buying an additional 6,465 shares during the last quarter. Finally, Addison Capital Co boosted its position in iShares Biotechnology ETF by 16.0% during the 1st quarter. Addison Capital Co now owns 33,045 shares of the financial services provider’s stock worth $5,580,000 after buying an additional 4,569 shares during the period. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Price Performance

IBB opened at $197.34 on Friday. iShares Biotechnology ETF has a fifty-two week low of $128.84 and a fifty-two week high of $199.05. The company’s 50 day moving average price is $175.36 and its two-hundred day moving average price is $172.67.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Monday, June 15th were paid a dividend of $0.0238 per share. The ex-dividend date of this dividend was Monday, June 15th. This represents a $0.10 annualized dividend and a dividend yield of 0.0%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.